BioSpace News Archive

Business

GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer

GlycoEra AG today announced the expansion of its Series A financing with an investment from Bristol Myers Squibb (BMS).

January 5, 2024
·
2 min read
Biotech Bay

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Jan 05, 2024

Rigel Pharmaceuticals, Inc. announced that it has granted awards pursuant to Rigel’s Inducement Plan, approved by the Compensation Committee of Rigel’s Board of Directors and granted as an inducement material to employees’ entering into employment with Rigel, in accordance with NASDAQ Listing Rule 5635.

January 5, 2024
·
1 min read
Pharm Country

Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 42nd Annual J.P. Morgan Healthcare conference on January 10, 2024 at 1:30pm ET.

January 5, 2024
·
1 min read
FDA

U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum Contagiosum

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S. Food and Drug Administration (FDA) has approved ZELSUVMI™ (berdazimer topical gel, 10.3%) for the treatment of molluscum contagiosum (molluscum) in adults and pediatric patients one year of age and older.

January 5, 2024
·
8 min read
Biotech Beach

Arrowhead Pharmaceuticals Closes Underwritten Offering with Gross Proceeds of $450.0 Million

Arrowhead Pharmaceuticals, Inc. announced that on January 5, 2024, it closed the previously announced underwritten registered offering of 15,790,000 shares of its common stock, par value $0.001 per share.

January 5, 2024
·
2 min read
BioCapital

PRECISIO BIOTIX TO PRESENT AT BIOTECH SHOWCASE™ 2024 and BFC GLOBAL HEALTHCARE CONFERENCE

Precisio Biotix today announced that it is presenting at both the BFC Global Healthcare Conference and Biotech Showcase™ 2024.

January 5, 2024
·
1 min read
PanGIA Biotech Plans Expanded Multi-Cancer Early Detection Liquid Biopsy Study

PanGIA Biotech, a US based biotechnology company with a mission to develop true liquid biopsy technology that is scalable for global impact, today announced that it is finalizing its three-year, prospective, multicenter, clinical study on prostate cancer liquid biopsy.

January 5, 2024
·
2 min read
Genetown

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 05, 2024

Agenus Inc. announced that the Compensation Committee of Agenus’ Board of Directors granted, as of January 2, 2024, inducement awards to Manuel Duenas and Benny Johnson in connection with their appointments as Head of Market Access and Senior Medical Director, respectively.

January 5, 2024
·
2 min read
Policy

LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th

LumiraDx Limited announced that it has received notification from The Nasdaq Stock Market LLC that its securities will be suspended from trading at the open of business on January 9, 2024 as a result of the Company’s failure to maintain compliance with Nasdaq’s continued listing standards.

January 5, 2024
·
2 min read
Business

Sobi’s Chairman of the Board resigns due to health reasons

Swedish Orphan Biovitrum AB’s Chairman of the Board Bo Jesper Hansen resigns, at his own request and with immediate effect, from his position as Chairman of the Board and board member due to health reasons.

January 5, 2024
·
1 min read